Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

168.77 +0.05 (+0.03%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,327,130
Open 169.25
Bid (Size) 164.43 (1)
Ask (Size) 186.34 (1)
Prev. Close 168.72
Today's Range 168.11 - 171.30
52wk Range 123.30 - 171.30
Shares Outstanding 122,180,759
Dividend Yield 1.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Grail Shares Spiked Wednesday: What's Going On?
Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test. 
Via Benzinga
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for. 
Via StockStory

Performance

YTD
+11.80%
+11.80%
1 Month
+11.28%
+11.28%
3 Month
+4.11%
+4.11%
6 Month
+11.68%
+11.68%
1 Year
+36.10%
+36.10%

More News

Read More
Encompass Health (EHC) Q4 Earnings: What To Expect
Via StockStory
Quest’s (NYSE:DGX) Q4: Beats On Revenue
Via StockStory
What 6 Analyst Ratings Have To Say About Quest Diagnostics
Via Benzinga
Why Quest Diagnostics Stock Was Blasting Higher Today
Via The Motley Fool
Analyst Expectations For Quest Diagnostics's Future
Via Benzinga
How Is The Market Feeling About Quest Diagnostics?
Via Benzinga
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Quest Diagnostics Stock Hits Over 2-Month High On Q4 Beat, Dividend Hike: Retail Cheer Grows
Via Stocktwits
Quest Diagnostics Delivers Q4 Earnings Beat: The Details
Via Benzinga
The Analyst Landscape: 8 Takes On Quest Diagnostics
Via Benzinga
(DGX) - Analyzing Quest Diagnostics's Short Interest
Via Benzinga
Quest Diagnostics EPS Tops Predictions
Via The Motley Fool
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Earnings Scheduled For January 30, 2025
Via Benzinga
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Via News Direct
Exposures Product Safety
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Via Benzinga
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
From Mainz BioMed NV
Via GlobeNewswire
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.